|Cell line type
|Human induced pluripotent stem cell (hiPSC)
Donor's gene variants:
|9th May 2022
No feedback available yet.
Login to share your feedback, experiences or results with the research community.
|Stanford Cardiovascular Institute (SCVI)
|* Is the cell line readily obtainable for third parties?
General Donor Information
Phenotype and Disease related information (Donor)
|A disease was diagnosed.
|Has the donor karyotype been analysed?
Other Genotyping (Donor)
|Is there genome-wide genotyping or functional data available?
External Databases (Donor)
|Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived?
|Was the consent voluntarily given?
|Has the donor been informed that participation will not directly influence their personal treatment?
|Can you provide us with a copy of the Donor Information Sheet provided to the donor?
|Provide contact information of the holder of the original Donor Information Sheet:
|Do you (Depositor/Provider) hold the original Donor Consent Form?
|Has the donor agreed to be re-contacted?
|Please indicate whether the data associated with the donated material has been pseudonymised or anonymised.
|Does consent explicitly allow the derivation of pluripotent stem cells?
|Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world?
|How may genetic information associated with the cell line be accessed?
|Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample?
|Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions?
|Name of accrediting authority involved?
|For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
|Source cell line name
|Human Skin fibroblast cells
|Source cell type
|Is reprogramming vector detectable?
Vector free reprogramming
|Type of used vector free reprogramming factor(s)
|Derived under xeno-free conditions
|Derived under GMP?
|Available as clinical grade?
Base medium: StemMACS
Main protein source: StemMACS brew
Serum concentration: %
Analysis of Undifferentiated Cells
Microbiology / Virus Screening
Karyotyping (Cell Line)
|Has the cell line karyotype been analysed?
Passage number: 10
Karyotyping method: Karyo+
Other Genotyping (Cell Line)